These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36011604)

  • 1. Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients.
    Hsieh MH; Wu YL; Tsao TC; Huang YW; Lin JC; Lee CY; Hsieh MJ; Yang SF
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
    Tang Y; Wang Y; Wang X; Liu Y; Zheng K
    Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Variants of lncRNA
    Hsieh MH; Lu HJ; Lin CW; Lee CY; Yang SJ; Wu PH; Chen MK; Yang SF
    J Pers Med; 2021 Apr; 11(5):. PubMed ID: 33925911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma.
    Wang YC; Tsao SM; Li YT; Lee CY; Tsao TC; Hsieh MJ; Yang SF
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33799753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Long Non-Coding RNA Growth Arrest-Specific 5 Genetic Variants with Diabetic Retinopathy.
    Lee CM; Yang YS; Kornelius E; Huang CN; Hsu MY; Lee CY; Peng SY; Yang SF
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke.
    Zheng Z; Liu S; Wang C; Han X
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationships of genetic polymorphisms of the long noncoding RNA growth arrest-specific transcript 5 with uterine cervical cancer.
    Weng SL; Ng SC; Lee YC; Hsiao YH; Hsu CF; Yang SF; Wang PH
    Int J Med Sci; 2020; 17(9):1187-1195. PubMed ID: 32547314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.
    Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
    Int J Med Sci; 2019; 16(11):1424-1429. PubMed ID: 31673232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis.
    Shen Z; She Q
    Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics.
    Weng WC; Chen CJ; Chen PN; Wang SS; Hsieh MJ; Yang SF
    Diagnostics (Basel); 2020 Apr; 10(5):. PubMed ID: 32354045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
    Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variants of
    Deng F; Zhu P; Liao C; Li S; Hu X; Wang Y; Wu Z; Huang S; Zhong W; Zhao B; Ma G; Li Y
    Biomed Res Int; 2021; 2021():6634253. PubMed ID: 33937403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations: A meta-analysis.
    Gao G; Liu C; Li X; Guan X; Yang X; Qin P
    Medicine (Baltimore); 2021 Oct; 100(41):e27415. PubMed ID: 34731115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer.
    Li QJ; Ma G; Guo HM; Sun SH; Xu Y; Wang BJ
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):19-24. PubMed ID: 29557411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA-GAS5 and its Promoter Region Polymorphism Associate with Helper Th17 Polarization and Predict Postoperative Pain and the Prognosis of the Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.
    Sha Z; Zhang P
    Iran J Immunol; 2022 Dec; 19(4):349-357. PubMed ID: 36585876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.
    Li Q; Ma G; Sun S; Xu Y; Wang B
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):478-482. PubMed ID: 29602737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer.
    Zheng Y; Song D; Xiao K; Yang C; Ding Y; Deng W; Tong S
    Oncotarget; 2016 Dec; 7(50):83727-83734. PubMed ID: 27863421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A.
    Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M
    DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma.
    Xu L; Xia C; Xue B; Sheng F; Xiong J; Wang S
    J Bone Oncol; 2018 Sep; 12():23-26. PubMed ID: 30013899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.